SPR Therapeutics fetches $25 mln Series C

Cleveland-based SPR Therapeutics Inc, a provider of neurostimulation technology for chronic and acute pain, has closed $25 million in Series C financing. Frontcourt Ventures and an unidentified family office led the round.

North AmericaUSBriefs